MetLife, Inc.

New York Stock Exchange
Back to all articles
Somewhat Bullish +35

Bank of Nova Scotia Decreases Position in MetLife, Inc. $MET

AI-generated analysis

📉 Bank of Nova Scotia decreased its MetLife position by 42.1% in Q1, selling 155,705 shares while retaining a stake worth $15.1 million.

📈 Activest Wealth Management increased its MetLife holdings by 205.8% in Q4 to own 315 shares valued at $25,000.

💰 JPMorgan Chase raised its price target on MetLife from $96.00 to $106.00 with an 'overweight' rating.

📊 Wells Fargo increased its target price from $95.00 to $101.00 and maintained an 'overweight' stance.

🎯 Piper Sandler boosted its price target to $90.00 while keeping a 'neutral' rating on the stock.

📉 MetLife reported Q1 EPS of $2.42, beating estimates, but revenue of $14.18 billion missed the $19.49 billion consensus.

💵 The company declared a quarterly dividend of $0.5925 per share with an annualized yield of 2.5%.

📈 MetLife's stock trades at a P/E ratio of 18.35 with a market cap of $60.91 billion.

🏦 Hedge funds and institutional investors collectively own 94.99% of the company's outstanding shares.

🗣️ Analyst consensus currently rates MetLife as a 'Moderate Buy' with an average price target of $100.50.

Bullish Signals
  • JPMorgan Chase raised its price target to $106.00 and assigned an 'overweight' rating, indicating strong institutional confidence.
  • Wells Fargo increased its price target to $101.00 with an 'overweight' rating, signaling positive outlook from major banks.
  • Jefferies Financial Group raised its target price to $103.00 and upgraded the rating to 'buy'.
  • MetLife beat quarterly EPS estimates of $2.27 by reporting $2.42 per share.
  • The company maintains a healthy return on equity of 22.60% and a net margin of 4.66%.
  • Activest Wealth Management significantly increased its stake by over 200%, suggesting bullish sentiment among smaller funds.
  • MetLife offers a consistent dividend yield of 2.5% with a payout ratio of 45.93%.
Risk Factors
  • Bank of Nova Scotia reduced its position by 42.1% in Q1, indicating a lack of interest from one of the largest institutional holders.
  • MetLife's quarterly revenue of $14.18 billion missed analyst estimates of $19.49 billion significantly.
  • Wall Street Zen downgraded MetLife from 'buy' to 'hold', reflecting some caution among analysts.
  • The stock is trading near its 52-week high of $94.86, which may limit immediate upside potential.
Full Analysis
Bank of Nova Scotia significantly reduced its stake in MetLife, Inc. (NYSE:MET) by 42.1% during the first quarter, selling 155,705 shares to hold a remaining position of 213,846 shares valued at $15.1 million. Conversely, several smaller institutional investors and wealth management firms increased their holdings in the fourth quarter, with Activest Wealth Management boosting its stake by over 200% to own 315 shares. Wall Street analysts have recently issued mixed but generally positive signals for MetLife. Major institutions including JPMorgan Chase, Wells Fargo, and Jefferies Financial Group raised their price targets to between $101 and $106, maintaining 'overweight' or 'buy' ratings. The consensus average price target stands at $100.50 with a 'Moderate Buy' rating, though Wall Street Zen recently downgraded the stock to a 'hold'. MetLife reported quarterly earnings on May 6th that beat EPS expectations of $2.27 with a result of $2.42, although revenue of $14.18 billion missed analyst estimates of $19.49 billion. The company maintains a market capitalization of $60.91 billion and has announced a quarterly dividend of $0.5925 per share payable on September 8th to shareholders of record on August 4th.